India's Aurobindo Pharma rises after unit resumes Kakinada facility output

Aurobindo Pharma

30/06/2025 06:24

** Shares of India's Aurobindo Pharma ARBN.NS climb 2.4%

** Drugmaker said its unit Lyfius Pharma has restarted production at Kakinada facility in southern state of Andhra Pradesh

** Stock, on an avg, rated "buy"; median TP 1370 rupees - data compiled by LSEG

** YTD stock down ~15%

(Reporting by Hritam Mukherjee in Bengaluru)

((Hritam.Mukherjee@thomsonreuters.com;))